RE: End of year16 Mar 2025 18:03
Evening Pharmall,
Interesting - do you currently own Kier or Costain? I have both, and agree they're both dirt cheap. Have held Costain for a fair while, and decided to average down instead off sell up after the charges on those overruning contracts tanked the SP 2019 and again 2020. Currently break-even. I would add more on current valuation and prospects, but have enough. I bought Kier the other week after results as well.
Have you looked at Hill and Smith? I've held for over a decade now, and they've been one of my best investments (I think I could have them as my specialist subject on Mastermind!). P/E of 20, so higher than UK piers like Kier and BB, but they compound every year (revenue, margin improvement, EPS, OP) and get 75% of revenue from US now. I think they could also benefit heavily from Trump's corporate tax giveaway for US-manafacturing firms down to 15% (if that gets passed in Congress or isn't just some pie-in-the-sky figure he blurted out pre-election).
Only other one on my radar is Renew Holdings. Held last year briefly, but opted to take a quick 10%, which was a blessing as they've come off the boil since and then were sold heavily after a January T/U said Rail revenue would be down on softness from latest control period. Swedebank have been buying heavily since the dip, up to 6% now.
Let me know what you come up with!